The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.
Considering your age, you might think that you don’t have to worry about urinary incontinence. While it’s true that it usually affects the elderly, it can happen to anyone. This article provides several types of urinary incontinence and when you should see a doctor. Read on to learn more.
4/9/19: INNOVO was approved by the United States Food and Drug Administration on November 13, 2018, and is the first ever transcutaneous electrical stimulator cleared by the FDA, offering U.S. women a safe, clinically effective and non-invasive choice to treat stress urinary incontinence
INNOVO® was approved by the United States Food and Drug Administration November 13, 2018, and is the first ever transcutaneous electrical stimulator cleared by the FDA, offering U.S. women a safe, clinically effective and non-invasive choice to treat stress urinary incontinence. In its pivotal multi-center randomized controlled clinical trial, 87.2% of INNOVO® users were dry or almost dry after a 12-week treatment period, with 80% of patients experiencing improvement in just 4 weeks.
Since the inception of their partnership five years ago, ATLATL Scientific and Miltenyi Biotec have worked closely together to leverage their respective expertise and resources.